Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Exploring High Growth Tech Stocks in the US Market

In This Article:

Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 22% over the past year, with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks often involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these promising growth projections.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

24.13%

24.28%

★★★★★★

Ardelyx

22.86%

54.70%

★★★★★★

AVITA Medical

33.33%

51.81%

★★★★★★

Alkami Technology

21.99%

102.65%

★★★★★★

AsiaFIN Holdings

51.75%

82.69%

★★★★★★

Alnylam Pharmaceuticals

21.39%

56.40%

★★★★★★

TG Therapeutics

30.33%

44.07%

★★★★★★

Clene

61.16%

59.11%

★★★★★★

Blueprint Medicines

22.61%

55.18%

★★★★★★

Travere Therapeutics

29.54%

61.86%

★★★★★★

Click here to see the full list of 226 stocks from our US High Growth Tech and AI Stocks screener.

Let's explore several standout options from the results in the screener.

Clearfield

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Clearfield, Inc. is a company that manufactures and sells fiber connectivity products both in the United States and internationally, with a market capitalization of approximately $492.81 million.

Operations: The company generates revenue primarily through its Clearfield segment, contributing $125.63 million, and Nestor Cables segment, adding $43.41 million.

Clearfield's recent product launch, the StreetSmart Ready Connect Terminal, underscores its commitment to addressing operator needs with innovative solutions tailored for compact and complex environments. This strategic move, coupled with robust conference engagements and a pivotal audit firm change to Deloitte, signals Clearfield's proactive stance in refining operational excellence and market reach. Despite a challenging fiscal year resulting in a net loss of $12.45 million from revenues of $166.71 million—a stark contrast to the previous year's $268.72 million—Clearfield is navigating through its recovery phase by focusing on U.S market-driven revenue growth projected between $170 million to $185 million for FY2025. These maneuvers are foundational as Clearfield steers towards profitability and sustains its competitive edge in the high-tech landscape.

NasdaqGM:CLFD Revenue and Expenses Breakdown as at Jan 2025
NasdaqGM:CLFD Revenue and Expenses Breakdown as at Jan 2025

Simulations Plus

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Simulations Plus, Inc. specializes in creating software for drug discovery and development, leveraging artificial intelligence and machine learning to model and simulate molecular properties, with a market cap of $567.61 million.